Liang et al.’s meta-analysis indicated that serum S100β levels were significantly elevated in epilepsy patients and serum S100B was the most valuable biomarker for epilepsy, aiding in clinical diagnosis and prognosis assessment [21]. Here, S100B is linked to epilepsy.